Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000030262 | SCV000107936 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030262 | SCV000052929 | benign | Lynch syndrome | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Eurofins Ntd Llc |
RCV000078310 | SCV000110151 | benign | not specified | 2013-06-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000162399 | SCV000212724 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000757473 | SCV000262398 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078310 | SCV000302870 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000625494 | SCV000430970 | benign | Lynch syndrome 5 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Color Diagnostics, |
RCV000162399 | SCV000685270 | benign | Hereditary cancer-predisposing syndrome | 2015-04-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000078310 | SCV000885715 | benign | not specified | 2019-04-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001618219 | SCV001847613 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000078310 | SCV002552308 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149586 | SCV003837644 | benign | Breast and/or ovarian cancer | 2021-11-18 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000625494 | SCV004015989 | benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000078310 | SCV000257221 | benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353756 | SCV000592602 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The p.Asn751Asn variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located near a splice site. In addition, this variant has been identified in dbSNP (rs2020913) as a polymorphism at about 1% frequency in a Yoruban cohort and in the exome variant server at an elevated frequency (~6 %) in African American individuals. In summary, based on this information this variant is considered benign. (it should be noted that the individual identified by our laboratory was indicated as "Black") | |
Genome Diagnostics Laboratory, |
RCV000625494 | SCV000745651 | benign | Lynch syndrome 5 | 2016-04-06 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000078310 | SCV001797583 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001618219 | SCV001918509 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078310 | SCV001958668 | benign | not specified | no assertion criteria provided | clinical testing |